1084 related articles for article (PubMed ID: 24215461)
41. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
[TBL] [Abstract][Full Text] [Related]
42. In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals.
Itoi S; Kano R; Hasegawa A; Kamata H
J Vet Med Sci; 2012 Aug; 74(8):1067-9. PubMed ID: 22467073
[TBL] [Abstract][Full Text] [Related]
43. In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
Simonetti O; Ganzetti G; Arzeni D; Campanati A; Marconi B; Silvestri C; Cirioni O; Gabrielli E; Lenci I; Kamysz W; Kamysz E; Giacometti A; Scalise G; Barchiesi F; Offidani A
Peptides; 2009 Oct; 30(10):1794-7. PubMed ID: 19591887
[TBL] [Abstract][Full Text] [Related]
44. In vitro activity of Penicillium chrysogenum antifungal protein (PAF) and its combination with fluconazole against different dermatophytes.
Galgóczy L; Papp T; Pócsi I; Hegedus N; Vágvölgyi C
Antonie Van Leeuwenhoek; 2008 Oct; 94(3):463-70. PubMed ID: 18574706
[TBL] [Abstract][Full Text] [Related]
45.
Singh SK; Patwa DK; Tilak R; Das A; Singh TB
Indian J Dermatol Venereol Leprol; 2019; 85(4):388-392. PubMed ID: 30950409
[TBL] [Abstract][Full Text] [Related]
46. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
[TBL] [Abstract][Full Text] [Related]
47. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
Santos DA; Hamdan JS
Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
[TBL] [Abstract][Full Text] [Related]
48. In vitro Azole Susceptibility Testing of Japanese Isolates of Itraconazole-Resistant Dermatophytes.
Nojo H; Hiruma J; Noguchi H; Hiruma M; Harada K; Makimura K; Kano R
Med Mycol J; 2023; 64(4):103-105. PubMed ID: 38030274
[TBL] [Abstract][Full Text] [Related]
49. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
Shehata AS; Mukherjee PK; Ghannoum MA
J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129
[TBL] [Abstract][Full Text] [Related]
50. MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
Shaw D; Singh S; Dogra S; Jayaraman J; Bhat R; Panda S; Chakrabarti A; Anjum N; Chowdappa A; Nagamoti M; Varshney U; Vanam HP; Savio J; Antony M; Rudramurthy SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015042
[TBL] [Abstract][Full Text] [Related]
51. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
[TBL] [Abstract][Full Text] [Related]
52. Effect of Lamisil and azole antifungals in experimental nail infection.
Richardson MD
Dermatology; 1997; 194 Suppl 1():27-31. PubMed ID: 9154398
[TBL] [Abstract][Full Text] [Related]
53. Anti dermatophytic activity of Azardirachta indica (neem) by invitro study.
Natarajan V; Pushkala S; Karuppiah VP; Prasad PV
Indian J Pathol Microbiol; 2002 Jul; 45(3):311-3. PubMed ID: 12785173
[TBL] [Abstract][Full Text] [Related]
54. Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Badiee P; Shokohi T; Hashemi J; Mohammadi R; Najafzadeh MJ; Amin Shahidi M; Ghasemi F; Jafarian H
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):15. PubMed ID: 36805670
[TBL] [Abstract][Full Text] [Related]
55. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile].
Díaz Jarabrán MC; Díaz González P; Espinoza Rodríguez J; Carrillo Muñoz AJ
Rev Iberoam Micol; 2015; 32(2):83-7. PubMed ID: 24794211
[TBL] [Abstract][Full Text] [Related]
56. Dermatophyte susceptibilities to antifungal azole agents tested in vitro by broth macro and microdilution methods.
Siqueira ER; Ferreira JC; Pedroso RS; Lavrador MA; Candido RC
Rev Inst Med Trop Sao Paulo; 2008; 50(1):1-5. PubMed ID: 18327478
[TBL] [Abstract][Full Text] [Related]
57. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran.
Ansari S; Hedayati MT; Zomorodian K; Pakshir K; Badali H; Rafiei A; Ravandeh M; Seyedmousavi S
Mycopathologia; 2016 Feb; 181(1-2):89-95. PubMed ID: 26369643
[TBL] [Abstract][Full Text] [Related]
58. In vitro antifungal activity of dragon's blood from Croton urucurana against dermatophytes.
Gurgel LA; Sidrim JJ; Martins DT; Cechinel Filho V; Rao VS
J Ethnopharmacol; 2005 Feb; 97(2):409-12. PubMed ID: 15707783
[TBL] [Abstract][Full Text] [Related]
59. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
Fernández-Torres B; Vázquez-Veiga H; Llovo X; Pereiro M; Guarro J
Chemotherapy; 2000; 46(6):390-4. PubMed ID: 11053904
[TBL] [Abstract][Full Text] [Related]
60. In vitro activity of seven azole compounds against some clinical isolates of non-dermatophytic filamentous fungi and some dermatophytes.
Oyeka CA; Gugnani HC
Mycopathologia; 1990 Jun; 110(3):157-61. PubMed ID: 2388682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]